Revonto
NDC 78670-003, dantrolene sodium, injection, powder, lyophilized, for solution, from USWM, LLC.
- Product NDC
- 78670-003
- Status
- Listed
- Labeler
- USWM, LLC
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078378
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/78670-003 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DANTROLENE SODIUM20 mg/60mL
Pharmacologic classes
Decreased Striated Muscle Contraction [PE]; Decreased Striated Muscle Tone [PE]; Skeletal Muscle Relaxant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 78670-003-67 | 78670000367 | 6 VIAL, GLASS in 1 CARTON (78670-003-67) / 60 mL in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/f1650487-32bd-4017-b9c2-b38829a531af
Use it
Look up 78670-003 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/78670-003 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 78670-003. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.